Birnam Oak Advisors »

Astria Therapeutics shares owned by Birnam Oak Advisors

Quarter-by-quarter ownership of Astria Therapeutics shares owned by Birnam Oak Advisors from 13F filings

Historical chart of Birnam Oak Advisors investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Birnam Oak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Birnam Oak Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.0M 690k 13.09

More positions owned by Birnam Oak Advisors

Cyberark Software SHS (CYBR)
Ishares Tr Msci Acwi Etf (ACWI)
Frontier Communications Pare
Norfolk Southern (NSC)
Electronic Arts (EA)
Comerica Incorporated
Ceridian Hcm Hldg
Chart Industries (GTLS)
PNM Resources (TXNM)
AES Corporation (AES)
EXACT Sciences Corporation (EXAS)
Echostar Corp Cl A (SATS)
Vanguard Index Fds Growth Etf (VUG)
Cidara Therapeutics Com New (CDTX)
Astria Therapeutics

View all positions for Birnam Oak Advisors

Top funds holding Astria Therapeutics

Perceptive Advisors
FMR
BlackRock
Glazer Capital
Millennium Management
Vanguard Group
UBS Group
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Driehaus Capital Management
Geode Capital Management
Nantahala Capital Management
Qube Research & Technologies
Omni Event Management
Man Group

View all funds holding Astria Therapeutics